Company profile: Pressure BioSciences
1.1 - Company Overview
Company description
- Provider of proprietary laboratory instrumentation and consumables: Pressure Cycling Technology (PCT) for controlled biomolecular interactions (cell lysis, biomolecule extraction) in biomarker discovery, drug design and forensics; BaroFold for high-pressure protein disaggregation/refolding to remove aggregates and enhance product safety and efficacy; and Ultra Shear Technology (UST) to make stable nanoemulsions, improving solubility and stability.
Products and services
- BaroFold Platform: Engineers high-pressure protein disaggregation and refolding, removing aggregates to improve protein therapeutics’ quality while enhancing product safety and efficacy
- Pressure Cycling Technology (PCT) Platform: Builds laboratory-grade alternating hydrostatic-pressure cycles to control biomolecular interactions, enabling cell lysis and biomolecule extraction for biomarker discovery, drug design, and forensics
- Ultra Shear Technology (UST) Platform: Produces ultra-high-pressure intense shear to form stable nanoemulsions of immiscible fluids, improving solubility and stability in pharmaceuticals and other products
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Pressure BioSciences
Cevec
HQ: Germany
Website
- Description: Provider of biopharmaceutical production expertise using a unique human cell-based expression system, developing therapeutic proteins and monoclonal antibodies with human glycosylation patterns. CAP-Go enables production of proteins beyond antibodies, including complex glycosylated proteins that are difficult to express in conventional cell lines.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cevec company profile →
Collagen Solutions
HQ: United States
Website
- Description: Provider of medical-grade collagen formulations and components for regenerative medicine, medical devices, and in-vitro diagnostics, offering custom collagen engineering, GMP contract manufacturing, and product development. Expertise includes native, soluble, fibrillar, powdered and freeze-dried collagen, tissue-engineered materials (pericardium, bone, tendons), and regulatory compliance to GMP, EDQM, ISO13485, ISO 22442.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Collagen Solutions company profile →
Ziylo
HQ: United Kingdom
Website
- Description: Provider of biomimetic glucose binding molecules (GBM) based on supramolecular chemistry for use in diabetes care, enabling Continuous Glucose Monitors (CGM) and Glucose Responsive Insulins (GRI), with a mission to help people with diabetes live more normal and longer lives.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Ziylo company profile →
Origimm Biotechnology
HQ: Austria
Website
- Description: Provider of biotechnology research specializing in discovery of antigens and functional drug targets.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Origimm Biotechnology company profile →
Dewpoint Therapeutics
HQ: United States
Website
- Description: Provider of condensate-modifying drugs and an AI-powered drug discovery platform focused on biomolecular condensates. Offers therapies targeting TDP-43 for ALS and neurodegenerative diseases and beta catenin for cancers such as colorectal cancer. Engages in partnerships with pharmaceutical companies to develop drugs for cardiovascular diseases, insulin resistance, and oncology.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Dewpoint Therapeutics company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Pressure BioSciences
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Pressure BioSciences
2.2 - Growth funds investing in similar companies to Pressure BioSciences
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Pressure BioSciences
4.2 - Public trading comparable groups for Pressure BioSciences
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →